C
Cella Medical Solutions
Develops 3D models aiding surgeons in complex surgery planning, improving clinical outcomes and reducing patient risk
About Cella Medical Solutions
Cella Medical Solutions, established in Murcia, Spain, in 2016, provides advanced technological services for surgical planning in complex procedures. The company was founded by Darío García Calderón, who serves as the CEO, and Miguel Rodriguez Velázquez, the current CTO. It operates on a B2B model, catering to both public and private hospitals, as well as surgeons across various specialties like general, digestive, cardiovascular, thoracic, and urology.
The core of Cella's business is its proprietary and patented 3D-MSP® technology, a platform that transforms 2D medical images, such as CT and MRI scans, into high-fidelity 3D virtual models of a patient's anatomy. These reconstructions are validated by specialist radiologists to ensure precision. This service provides surgeons with a detailed, interactive digital twin of the organ to be operated on, which can be viewed on any PC, tablet, or smartphone without special software. The platform allows for simulating resections, taking measurements, and isolating anatomical structures, offering critical information that helps in making more precise decisions. Beyond virtual models, the company also offers physical 3D-printed anatomical models, which can be sterilized for use in the operating room, and is developing solutions in augmented reality and integration with surgical robots.
The business generates revenue by providing these personalized surgical planning services. Hospitals and surgical teams can request a model through an online process by uploading the patient's DICOM images; Cella's team of engineers and radiologists then creates and delivers the 3D model via its web platform. This approach is designed to improve clinical outcomes, reduce patient risk, shorten intervention times, and generate cost savings for healthcare institutions. The company has supported over 10,000 complex surgeries and is utilized by more than 150 hospitals. Cella has secured significant funding, including a €10 million investment from Moira Capital Partners, to support its national consolidation and international expansion.
Source: Dealroom company dataNews
Open roles
Cella Medical Solutions in its local ecosystem
The Cella Medical Solutions office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Moira Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cella Medical Solutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cella Medical Solutions on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


